ATAI - CIK 0001840904
ATAI Life Sciences N.V. has filed 320 documents with the SEC between 2021 and 2026. The most frequent type is insider trade (112 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Insider sale notice | 144 | 2026-03-20 | - |
| Insider sale notice | 144 | 2026-02-26 | - |
| 15-12G | - | 2025-12-31 | - |
| POSASR | - | 2025-12-31 | - |
| S-8 POS | - | 2025-12-31 | - |
| Major company event | 8-K | 2025-12-05 | 2025-12-05 |
| 424B7 | - | 2025-12-05 | - |
| Insider trade | 4 | 2025-11-26 | 2025-11-25 |
| Quarterly report | 10-Q | 2025-11-12 | 2025-09-30 |
| Major company event | 8-K | 2025-11-12 | 2025-11-12 |
| Insider trade | 4 | 2025-11-06 | 2025-11-05 |
| Insider trade | 4 | 2025-11-06 | 2025-11-05 |
| Insider trade | 4 | 2025-11-06 | 2025-11-04 |
| New insider ownership | 3 | 2025-11-06 | 2025-11-05 |
| New insider ownership | 3 | 2025-11-06 | 2025-11-05 |
| Major company event | 8-K | 2025-11-05 | 2025-11-05 |
| 424B7 | - | 2025-11-05 | - |
| Major company event | 8-K | 2025-11-05 | 2025-11-05 |
| Major company event | 8-K | 2025-11-04 | 2025-11-04 |
| 425 | - | 2025-10-27 | - |
| Major company event | 8-K | 2025-10-27 | 2025-10-23 |
| Major company event | 8-K | 2025-10-21 | 2025-10-20 |
| SCHEDULE 13D/A | - | 2025-10-20 | - |
| Major company event | 8-K | 2025-10-20 | 2025-10-16 |
| Prospectus supplement | 424B5 | 2025-10-17 | - |
| Prospectus supplement | 424B5 | 2025-10-16 | - |
| Proxy materials | DEFA14A | 2025-10-16 | - |
| Major company event | 8-K | 2025-10-16 | 2025-10-16 |
| Proxy materials | DEFA14A | 2025-10-10 | - |
| Major company event | 8-K | 2025-10-10 | 2025-10-10 |
| Insider trade | 4 | 2025-10-03 | 2025-10-01 |
| New insider ownership | 3 | 2025-10-03 | 2025-10-01 |
| Insider trade | 4 | 2025-10-02 | 2025-09-30 |
| S-3ASR | - | 2025-09-29 | - |
| Proxy materials | DEFA14A | 2025-09-29 | - |
| Major company event | 8-K | 2025-09-29 | 2025-09-29 |
| DEFM14A | - | 2025-09-24 | - |
| Proxy materials | DEFA14A | 2025-09-23 | - |
| Major company event | 8-K | 2025-09-23 | 2025-09-23 |
| SCHEDULE 13D/A | - | 2025-08-18 | - |
| Insider trade | 4 | 2025-08-18 | 2025-08-14 |
| Insider trade | 4 | 2025-08-15 | 2025-08-13 |
| Proxy materials | DEFA14A | 2025-08-14 | - |
| Major company event | 8-K | 2025-08-14 | 2025-08-14 |
| Quarterly report | 10-Q | 2025-08-14 | 2025-06-30 |
| Insider sale notice | 144 | 2025-07-02 | - |
| Proxy materials | DEFA14A | 2025-07-02 | - |
| Proxy materials | DEFA14A | 2025-07-02 | - |
| Insider sale notice | 144 | 2025-07-01 | - |
| Proxy materials | DEFA14A | 2025-07-01 | - |